Former FDA Commissioner Pfizer post contains views of ex-head of agency on the recent approval of Pfizer-BioNTech vaccine in the country.
The FDA approval of Pfizer-BioNTech on 24th August 2021 is welcome news for people of the United States in particular and the world in general. According to Former FDA Commissioner Pfizer, vaccine approval is a welcome step for countries to fight against deadly coronavirus pandemic since he has been in that place and knows the lengthy and time-consuming process to authorize any medicine fully.
Previously the vaccination was approved for giving in emergencies, and the doctor has to follow FDA guidelines for administering it to their patients.
What Does Full Authorization Changes For Pfizer-BioNTech?
The three vaccines used in the United States against coronavirus are Pfizer-BioNTech, Moderna, and Johnson& Johnson. Two shots of Pfizer and Moderna are required for complete vaccination, while the third one is entirely done in a single dose.
In the words of Mark McClellan, Former FDA Commissioner Pfizer, full authorization will increase the vaccination rate further as it will give more confidence to the people regarding its safety. FDA approval is a win-win situation for all the stakeholders, be it the company, the people of the agency monitoring the pandemic situation.
Some key points regarding full approval of vaccine:
- Till now vaccine was authorized for use in an emergency only.
- It will allow the use of vaccines even after the pandemic emergency gets over.
- Pfizer can continue manufacturing the vaccine and sell it in the market for public use on doctor’s recommendation.
Former FDA commissioner Pfizer Vaccine Approval and Delta Spread:
5.11 billion vaccine dose has been administered in 183 countries to vaccinate about one-third of the global population roughly. The vaccination rate in America is above 50 percent, and more than 60% of the population has received the single dose. Mark McClellan stated how this approval would affect the future vaccination drive in an interview with Bloomberg.
Some of them are listed below for the benefit of the audience:
- Approval will instill confidence in general people, and hence vaccination rate will increase.
- University and colleges waiting for approval will make it mandatory for students and teachers.
- People can go for a booster dose as it will strengthen the immunity against delta variants.
Former FDA Commissioner Pfizer Approval Will Increase Vaccine Mandate:
Government all over the world are trying to make covid-19 vaccination mandatory in public places. At the same time, in many countries, they have left the decision-making on employers and the authority of individual organizations.
With Pfizer getting full approval, it is expected that many more companies and institutions will bring a soft mandate for individuals getting vaccinated. Former FDA commissioner feels that following may change in soft mandate status.
- Vaccine mandate requires people to get vaccinated or else face covid-19 protocol.
- Approval will see a rise in companies and institutions enacting vaccine mandates.
- Government agencies and the Pentagon are expected to do it for their employees.
- The people will readily accept the mandate after Pfizer’s approval.
Final verdict:
Former FDA Commissioner Pfizer post feels that the words of Mark McClellan are of great relevance as he knows the procedure and value of getting FDA Approval for public acceptance. This approval will also allow many fence-sitters to join the vaccination derive and clear the mind of many hesitant people in taking their first shot.
People vaccinated with the Pfizer vaccine can share their experience in the comment section to help others join the vaccination drive. They can also give their opinion related to the post below. To know more about Pfizer approval, read it here.
Also Read : – chantix recall 2021 {Aug} Know All About it In Detail!